During the last three months, 15 analysts shared their evaluations of FMC FMC, revealing diverse outlooks from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 5 | 7 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 1 | 0 | 0 |
| 2M Ago | 0 | 1 | 1 | 0 | 0 |
| 3M Ago | 2 | 4 | 5 | 0 | 0 |
Analysts have recently evaluated FMC and provided 12-month price targets. The average target is $72.0, accompanied by a high estimate of $98.00 and a low estimate of $59.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 25.77%.
Understanding Analyst Ratings: A Comprehensive Breakdown
The perception of FMC by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Brian Wright | Roth MKM | Announces | Buy | $74.00 | - |
| Joel Jackson | BMO Capital | Lowers | Market Perform | $63.00 | $80.00 |
| Arun Viswanathan | RBC Capital | Maintains | Outperform | $61.00 | - |
| Joshua Spector | UBS | Lowers | Neutral | $59.00 | $64.00 |
| Arun Viswanathan | RBC Capital | Lowers | Outperform | $61.00 | $80.00 |
| Arun Viswanathan | RBC Capital | Lowers | Outperform | $80.00 | $105.00 |
| Joel Jackson | BMO Capital | Lowers | Outperform | $80.00 | $90.00 |
| Frank Mitsch | Fermium Research | Lowers | Hold | $62.00 | $85.00 |
| Vincent Andrews | Morgan Stanley | Lowers | Equal-Weight | $70.00 | $100.00 |
| Aleksey Yefremov | Keybanc | Lowers | Overweight | $83.00 | $107.00 |
| Adam Samuelson | Goldman Sachs | Lowers | Neutral | $59.00 | $135.00 |
| Steve Byrne | B of A Securities | Announces | Neutral | $63.00 | - |
| Richard Garchitorena | Wells Fargo | Lowers | Equal-Weight | $73.00 | $99.00 |
| Kevin McCarthy | Vertical Research | Announces | Buy | $94.00 | - |
| Christopher Parkinson | Mizuho | Lowers | Buy | $98.00 | $122.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to FMC. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of FMC compared to the broader market.
- Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of FMC's stock. This comparison reveals trends in analysts' expectations over time.
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of FMC's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on FMC analyst ratings.
About FMC
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
A Deep Dive into FMC's Financials
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Negative Revenue Trend: Examining FMC's financials over 3 months reveals challenges. As of 30 September, 2023, the company experienced a decline of approximately -28.7% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Net Margin: FMC's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -0.36%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): FMC's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -0.11%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): FMC's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -0.03%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a high debt-to-equity ratio of 1.25, FMC faces challenges in effectively managing its debt levels, indicating potential financial strain.
Understanding the Relevance of Analyst Ratings
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
